These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 22999910)

  • 1. Rosuvastatin inhibits spontaneous and IL-1β-induced interleukin-6 production from human cultured osteoblastic cells.
    Lazzerini PE; Capperucci C; Spreafico A; Capecchi PL; Niccolini S; Ferrata P; Frediani B; Galeazzi M; Laghi-Pasini F
    Joint Bone Spine; 2013 Mar; 80(2):195-200. PubMed ID: 22999910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simvastatin inhibits cytokine production and nuclear factor-kB activation in interleukin 1beta-stimulated synoviocytes from rheumatoid arthritis patients.
    Lazzerini PE; Lorenzini S; Selvi E; Capecchi PL; Chindamo D; Bisogno S; Ghittoni R; Natale MR; Caporali F; Giuntini S; Marcolongo R; Galeazzi M; Laghi-Pasini F
    Clin Exp Rheumatol; 2007; 25(5):696-700. PubMed ID: 18078616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin inhibits human airway smooth muscle cells mitogenic response to eicosanoid contractile agents.
    Capra V; Rovati GE
    Pulm Pharmacol Ther; 2014 Feb; 27(1):10-6. PubMed ID: 23806820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion.
    Mayer C; Gruber HJ; Landl EM; Pailer S; Scharnagl H; Truschnig-Wilders M; März W
    Int J Clin Pharmacol Ther; 2007 Jun; 45(6):319-27. PubMed ID: 17595889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts.
    Stein SH; Dean IN; Rawal SY; Tipton DA
    J Periodontal Res; 2011 Aug; 46(4):483-90. PubMed ID: 21463327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rosuvastatin on cytokines after traumatic head injury.
    Sánchez-Aguilar M; Tapia-Pérez JH; Sánchez-Rodríguez JJ; Viñas-Ríos JM; Martínez-Pérez P; de la Cruz-Mendoza E; Sánchez-Reyna M; Torres-Corzo JG; Gordillo-Moscoso A
    J Neurosurg; 2013 Mar; 118(3):669-75. PubMed ID: 23289819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosuvastatin promotes osteoblast differentiation and regulates SLCO1A1 transporter gene expression in MC3T3-E1 cells.
    Monjo M; Rubert M; Ellingsen JE; Lyngstadaas SP
    Cell Physiol Biochem; 2010; 26(4-5):647-56. PubMed ID: 21063102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HMG-CoA reductase inhibitor rosuvastatin inhibits plasminogen activator inhibitor-1 expression and secretion in human adipocytes.
    Laumen H; Skurk T; Hauner H
    Atherosclerosis; 2008 Feb; 196(2):565-73. PubMed ID: 17692320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new HMG-CoA reductase inhibitor, rosuvastatin, exerts anti-inflammatory effects on the microvascular endothelium: the role of mevalonic acid.
    Stalker TJ; Lefer AM; Scalia R
    Br J Pharmacol; 2001 Jun; 133(3):406-12. PubMed ID: 11375257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6, IL-1β, and TNF-α only in combination influence the osteoporotic phenotype in Crohn's patients via bone formation and bone resorption.
    Blaschke M; Koepp R; Cortis J; Komrakova M; Schieker M; Hempel U; Siggelkow H
    Adv Clin Exp Med; 2018 Jan; 27(1):45-56. PubMed ID: 29521042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
    Satoh M; Tabuchi T; Itoh T; Nakamura M
    Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of geranylgeranylation by rosuvastatin upregulates eNOS expression in human venous endothelial cells.
    Landsberger M; Jantzen F; Könemann S; Felix SB
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1005-9. PubMed ID: 16165089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosuvastatin suppresses the inflammatory responses through inhibition of c-Jun N-terminal kinase and Nuclear Factor-kappaB in endothelial cells.
    Kim YS; Ahn Y; Hong MH; Kim KH; Park HW; Hong YJ; Kim JH; Kim W; Jeong MH; Cho JG; Park JC; Kang JC
    J Cardiovasc Pharmacol; 2007 Jun; 49(6):376-83. PubMed ID: 17577102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HMG-CoA reductase inhibitor on experimental autoimmune myocarditis.
    Liu X; Li B; Wang W; Zhang C; Zhang M; Zhang Y; Xia Y; Dong Z; Guo Y; An F
    Cardiovasc Drugs Ther; 2012 Apr; 26(2):121-30. PubMed ID: 22382902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro.
    Fisher JE; Rogers MJ; Halasy JM; Luckman SP; Hughes DE; Masarachia PJ; Wesolowski G; Russell RG; Rodan GA; Reszka AA
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):133-8. PubMed ID: 9874784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.
    He F; Zhao J; Guo R; Liang Y
    Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mevalonate-suppressive dietary isoprenoids for bone health.
    Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
    J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of rosuvastatin on the production and activation of matrix metalloproteinase-2 and migration of cultured rat vascular smooth muscle cells induced by homocysteine.
    Shi YF; Chi JF; Tang WL; Xu FK; Liu LB; Ji Z; Lv HT; Guo HY
    J Zhejiang Univ Sci B; 2013 Aug; 14(8):696-704. PubMed ID: 23897788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts.
    Viereck V; Gründker C; Blaschke S; Frosch KH; Schoppet M; Emons G; Hofbauer LC
    J Cell Biochem; 2005 Dec; 96(6):1244-53. PubMed ID: 16152630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.